Safe, Natural, Effective Weight Loss...Virtually

GLP-1 receptor agonists (such as semaglutide and tirzepatide) have a well-documented list of side effects. Because these medications work by slowing down digestion and mimicking gut hormones that signal fullness to the brain, the vast majority of side effects are gastrointestinal.

GLP-1 receptor agonists (such as semaglutide and tirzepatide) have a well-documented list of side effects. Because these medications work by slowing down digestion and mimicking gut hormones that signal fullness to the brain, the vast majority of side effects are gastrointestinal.


Common Side Effects (Mild to Moderate)

These are typically most noticeable when first starting the medication or when increasing the dose, and they often improve over time as the body adjusts.

  • Nausea and Vomiting: Affects up to half of all users, usually peaking during the first few weeks of treatment.
  • Bowel Changes: This can include diarrhea (often early on) or moderate-to-severe constipation (which can persist longer).
  • Stomach Discomfort: Bloating, gas, heartburn/acid reflux, and general abdominal pain.
  • Fatigue and Headaches: Often linked to a rapid reduction in caloric intake or initial dehydration.
  • Dizziness: Mild lightheadedness can occur, sometimes due to changes in blood sugar or hydration.
  • Injection Site Reactions: Temporary redness, itching, or small bumps where the medication was injected.

Severe or Rare Side Effects (Require Medical Attention)

While uncommon, these are serious risks associated with GLP-1 therapy that require prompt evaluation by a healthcare provider.

  • Pancreatitis: Severe, persistent abdominal pain that often radiates to the back, sometimes accompanied by intractable vomiting.
  • Gallbladder Problems: An increased risk of gallstones or gallbladder inflammation (cholecystitis), frequently triggered by rapid weight loss.
  • Gastroparesis (Stomach Paralysis): Severe slowing of the stomach muscles, leading to persistent vomiting of undigested food and severe bloating.
  • Intestinal Blockage (Ileus): A rare but serious complication involving partial or complete paralysis of the intestines.
  • Acute Kidney Injury: Usually caused by severe dehydration resulting from prolonged vomiting or diarrhea.
  • Hypoglycemia (Low Blood Sugar): While rare when GLP-1s are used alone, the risk increases significantly if they are taken alongside other diabetes medications like insulin or sulfonylureas.
  • Worsening Retinopathy: For patients with type 2 diabetes, rapid improvements in blood sugar can sometimes temporarily worsen diabetic eye disease.

Other Notable Effects

  • “Ozempic Face”: A colloquial term for the hollowed-out, sagging, or aged appearance of facial skin caused by rapid fat loss in the face (this can happen with any rapid weight loss).
  • Muscle Mass Loss: Rapid weight loss can cause a loss of lean muscle tissue alongside fat if adequate protein intake and resistance training are not maintained.
  • Anhedonia or Mood Changes: Some users report feeling emotionally “flat” or experiencing a loss of pleasure in everyday activities, likely due to the medication blunting dopamine signaling pathways.
  • Thyroid Cancers (Boxed Warning): In rodent studies, these medications increased the risk of thyroid C-cell tumors. While this risk hasn’t been definitively proven in humans, GLP-1s are contraindicated for individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Note: If you are experiencing side effects that are unmanageable, or if you develop severe abdominal pain, persistent vomiting, or signs of an allergic reaction (swelling, hives, trouble breathing), you should contact a doctor or seek emergency medical care immediately.